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Abstract
Introduction—Apical periodontitis is an inflammatory disease of the periradicular tissues caused
by the host’s immune response to infection of the root canal system. microRNAs (miRNAs) have
been shown to play an important role in the regulation of inflammation and the immune response;
however, their role in the pathogenesis of endodontic periapical disease has not been explored.
The purpose of this study was to examine the differential expression of miRNAs in diseased
periapical tissues as compared to healthy controls.
Methods—We first compared miRNA profiles in diseased periapical tissues collected from
patients undergoing endodontic surgery to that of healthy pulps using microarray analyses. The
target genes of the differentially expressed miRNAs were identified using miRWalk and
PUBMED. Selected miRNAs linked to inflammation and the immune response were then
confirmed in a separate cohort of diseased and healthy tissues using quantitative RT-PCR. Healthy
pulps and periodontal ligaments were used as controls. Data was normalized to the level of
SNORD 44 which served as an endogenous control.
Results—Of the 381 miRNAs identified using microarray, 24 miRNAs were down-regulated in
diseased periapical tissues compared to controls (n=13) (P<0.003). The down-regulation of 7
miRNAs was confirmed from 9 selected miRNAs using qRT-PCR (n=19) (P<0.05). Target genes
of these miRNAs include key mediators in the immune and inflammatory response such as of
IL-6, MMP-9 and TGF-β.
Conclusions—These findings offer new insight into the pathogenesis of endodontic disease and
have the potential to impact the development of new methods for prevention, diagnosis, and
treatment of apical periodontitis.
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Introduction
The discovery of microRNAs (miRNAs) is one of the major scientific breakthroughs in
recent years and has dramatically changed the view of a linear relationship between gene
and protein expression (1). miRNAs are short, non-coding, single stranded RNA molecules
that mediate RNA-interference through post-transcriptional modulation of gene expression.
They silence genes by binding to complementary sequences of their respective target
messenger RNAs either inhibiting their translation into proteins or initiating cleavage of the
messenger RNA leading to its degradation (2).
miRNAs play a fundamental role in mediating biological events and are involved in virtually
all physiologic processes (1). They have also been implicated in a multitude of pathologic
states such as inflammatory diseases, cancer, developmental abnormalities, cardiovascular
diseases and neurodegenerative disorders (3–7). miRNAs are emerging as novel biomarkers
of disease, prognostic indicators, and targets for drug therapy. Their high sequence
conservation across species and tissue specificity make them ideal biomarkers (8). Stable
miRNAs have recently been identified in many body fluids including saliva and plasma,
which allows for a non-invasive means to measure miRNA profiles (9, 10). Functional
miRNAs have been discovered in exosomes, which presents a novel strategy to deliver RNA
therapeutic agents (11). miRNA-based technology is currently being implemented in a wide
range of applications such as cancer diagnosis and prognosis, predicting risk of transplant
rejection, determining the quality of stored blood, and prenatal diagnostics (12).
The role of miRNAs in orofacial inflammation is just beginning to be explored. Altered
miRNA expression levels have been demonstrated in periodontal disease by comparing
healthy and inflamed gingival tissues (13–15). The first miRNA study in the field of
endodontics found significant differential expression of several miRNAs between healthy
and diseased pulps (16). Although some insight has been gained on the role of miRNAs in
endodontic pulpal disease, its role in endodontic periapical pathogenesis has not been
explored. The purpose of this study is to determine the differential expression of miRNAs in
diseased periapical tissues by comparing the miRNA profiles of diseased periapical tissues
and healthy control tissues.
Materials and Methods
Study participants and sample collection
This study was approved by our Institutional Review Board and written informed consent
was obtained from all study participants. The inclusion criteria were patients of age ≥12
years old and American Society of Anesthesiologists class I or II. Patients who were
immune compromised or currently taking antibiotics or other medications known to
influence the immune response were excluded from the study.
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Diseased periapical tissues were collected from teeth undergoing surgical endodontic
treatment (apicoectomy). These teeth had previous non-surgical endodontic treatment and
were associated with a non-healing periapical lesion. The majority of these cases were
associated with asymptomatic chronic lesions with the exception of two cases, in which pain
symptoms were associated with the tooth from which the sample was collected. During the
apicoectomy procedure, granulation tissue from the periapical lesion was curetted from the
bony cavity prior to root end resection. Two different types of tissues were used as controls:
normal periodontal ligament (PDL) and pulp tissues. These were collected from extracted
non-carious third molars or premolars. Healthy PDL was collected immediately following
extraction using a scaling instrument to separate the tissues from the surface of the root.
Pulp tissue was extirpated using sterilized barbed broaches immediately after extraction.
Tissues samples were placed in a sterile eppendorf tube with 0.5ml RNAsafer Stabilizer
Reagent (VWR, Bridgeport, NJ) and stored at −80°C until processing. Thirteen samples
(eight diseased periapical tissues and five healthy pulps) were used for the microarray
experiment and 19 samples (eight diseased periapical tissues, eight periodontal ligaments
and three healthy pulps) were used for qRT-PCR.
RNA isolation and miRNA microarray
Samples were thawed on ice and centrifuged at 4°C for 2 minutes at 12,000 rpm to remove
the stabilizer reagent. Total RNA was extracted using the miRNeasy Mini kit (Qiagen,
Valencia, CA) according to manufacturer’s instructions. The RNA was quantitated using the
NanoDrop (Thermo Scientific, Wilmington, DE) and RNA integrity assessed using the 2100
Bioanalyzer (Agilent, Foster City, CA). The miRNA expression profiles were interrogated
using Human miRNA Microarrays (V3) and the miRNA Complete Labeling and Hyb Kit
(both from Agilent Technologies, Santa Clara, CA). The microarrays consist of glass slides
containing 8 identical 15K oligonucleotide microarrays incorporating probes for 866 human
miRNAs represented from the Sanger miRBase 12.0. The procedure was performed as
described previously (16). Slides were scanned using the Agilent Microarray Scanner and
the Agilent Feature Extraction Software version 10.5.1.1 (both from Agilent, Foster City,
CA).
Bioinformatics miRNA analysis and target selection
Potential mRNA target genes for differentially expressed miRNAs in diseased periapical
tissues were identified using miRWalk (http://www.rna.uni-heidelberg.de/apps/zmf/
mirwalk/index_html). miRWalk is a comprehensive database that provides information on
human and murine miRNAs on their predicted and validated targets associated with genes,
pathways, diseases, organs, cell lines and transcription factors. It is based on a comparison
of computed mRNA 3′ UTRs miRNA binding sites with 8 miRNA-target prediction
programs. Candidate mRNAs were selected if they were identified as validated miRNA
targets in at least 5 out of 8 databases and were linked to immunity, inflammation and pain
by GO Biological Process (www.geneontology.org). Results from miRWalk and PUBMED
search were integrated to reach our final results.
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9 miRNAs that demonstrated significant differential expression in the microarray analysis
and are linked to inflammation and the immune response were selected for further validation
using qRT-PCR. miScript primers and miScript II RT Kit were purchased from Qiagen
(Germantown, MD, USA). Total RNA (450ng) was reverse transcribed using cDNA
synthesis kit according to manufacturer’s instructions. The PCR reactions were run using
miRNA specific primers and the miScript universal primer (Qiagen, Catalogue #:
MS00006692, MS00006699, MS00008841, MS00031500, MS00007588, MS00009744,
MS00031878, MS00010906, MS00003570, MS00007518). Reaction mixes were prepared
using 2X EvaGreen Master Mix (Biotium, Hayward, CA, USA), 2 μl of 1:10 diluted cDNA,
and 10 pmoles of each forward and reverse primer (total 20 μl). The real-time PCR was
carried out in the StepOne 7500 thermocycler (Applied Biosystems, Carlsbad CA, USA).
SNORD 44 served as an internal control and all reactions were run in triplicates. SNORD 44
was selected from a total of 3 endogenous controls due to its’ relatively constant expression
in the tissues used for this study.
Statistical analysis
For microarray data analysis, any expression value that was lower than the reported error for
that particular gene (which includes negative expression values) was set to be equal to the
estimated error rate. Quantile normalization was applied to the expression data. To identify
genes that were differentially expressed in each group, we applied a permutation test to test
the null hypothesis that the mean expression of each gene was the same in both groups. An
exact hypothesis test was used since the sample size was small. We used the resulting p-
values to estimate the false discovery rate q-value when the differential expression of each
miRNA is called “significant”. For each resulting p-value, we computed the q-value, which
is defined to be the false discovery rate when all tests with a p-value less than or equal to the
given p-value are called “significant.” For qRT-PCR analysis, the relative expression of
miRNA as compared SNORD44 was computed using the 2(−ΔΔCt) method (17). Significance
was determined by applying Welch’s t-test to the relative fold changes of periapical tissues
and control tissues. Differences were considered significant when the probability value was
less than 5% (P<0.05).
Results
No significant differences were noted in gender distribution between experimental and
control groups. However, there was a significant difference in age between subjects from
which periapical tissue were collected and subjects from which healthy PDL and pulp were
collected (P < 0.05). The mean age of the periapical group was 53 yrs. (±15), while that of
the PDL controls was 28 yrs. (±16), and that of the pulp group was 18 yrs. (±3).
Microarray results
Three hundred and eighty one miRNAs were identified in periapical tissues, of which 24
miRNAs were significantly down-regulated in diseased periapical tissues compared to
healthy pulp tissues (P < .003, q < .08). Fifteen miRNAs showed a fold regulation of −2 to
−5 and six miRNAs had more than a -5fold regulation (Fig. 1). Of the 24 down-regulated
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miRNAs identified, nine miRNAs that are linked to inflammation and immunity were
selected for further analysis with qRT-PCR.
qRT-PCR results
The expression of the nine miRNAs examined did not differ between healthy pulps and
PDL. Seven of the nine miRNAs examined were downregulated in diseased periapical
tissues as compared to healthy pulp tissues (P ≤ .001) (Fig 2). These same seven miRNAs
were also down-regulated when comparing diseased periapical tissues to healthy PDL (P ≤ .
005) (Fig. 3). On comparing the relative fold change in miR-95 expression in diseased
periapical lesions as compared to normal PDL, the levels were not altered (1.2 fold) to the
extent observed for other miRNAs. Nonetheless, the expression pattern is qualitatively
similar to data comparing the diseased samples to healthy pulps as well as the microarray
data.
Bioinformatics data
The potential targets of the differentially expressed miRNAs identified include key
cytokines involved in inflammation (IL-6, IL-10), chemokines (CCL8), pathogen
recognition receptors (TLR-4), growth factors (TGF-β1, VEGF-α), and proteins of the
matrix metalloproteinase (MMP) family (MMP-9).”(Table 1).
Discussion
In this study, multiple miRNAs from the miR-181 family (miR-181a*, miR-181b and
miR-181c) were demonstrated to be significantly down-regulated in diseased periapical
tissues compared to healthy controls. Down-regulation of miRNAs, which are negative
regulators themselves, results in an increase in their respective target messenger RNAs. The
targets of miR-181a* include toll-like receptor-4 (TLR-4) (18), which plays a key role in
pathogen recognition and activation of the innate immune response, and IL-6, which
stimulates neutrophil production and supports B-cell maturation (19). miR-181b targets
CCL-8, MMP-9 and TGF-β1, which are involved in a wide range of inflammatory
pathways. For example, CCL-8 is chemotactic for and activates several immune cells
including monocytes, T cells and NK cells (20). MMP-9 is closely associated with
macrophage differentiation and TGF-β1 increases collagen biosynthesis and fibroblast
proliferation (21, 22). The targets of miR-181c include SOCS1, which is involved in the
LPS response, and IL-2, which plays an essential role in the immune response to antigenic
stimuli and is important for the proliferation of T and B lymphocytes (23). The miR-181
family is also notable for altering T-cell receptor signaling and increasing IFN-γ/IL-17
production by Th1/17 cells (24).
Increasing evidence supports the role of the miR-181 family in inflammatory pathologies.
Circulating levels of miR-181a, miR-181a-2* and miR181c in whole blood were
significantly lower in patients diagnosed with complex regional pain syndrome, a disorder in
which neurogenic inflammation plays a key role (25). Blood plasma levels of miR-181b was
found to be lower in patients with sepsis (a whole body inflammatory condition due to
infection) and in animal models of sepsis (26). Data from our previous study show that
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members of the miR-181 family are significantly down-regulated in inflamed human pulps
as compared to normal pulps (16). Conversely, miR-181c is upregulated in inflamed
gingival tissues (15). These differences in expression of miR-181c in distinct inflammatory
pathologies could possibly be due to differences in the type of infection or the host tissue or
the sampling point after initiation of inflammation. Thus, despite the similarities in
expression of this miRNA family with other inflammatory conditions, it is important to note
that a direct comparison is to be avoided due to the diversity of the complex regulatory
mechanisms across different pathologic processes and different tissues.
In addition to the miR-181 family, miR-24-1*, miR-95, miR-149 and miR-455-3p were
significantly down-regulated in diseased periapical tissues. These miRNAs also have a
variety of targets that are implicated in the immune and inflammatory response. For
example, miR-149 targets VEGF-α, which acts on endothelial cells to mediate increased
vascular permeability and promote cell migration to the site of inflammation (27).
miR-455-3p targets TLR-4 as well as IL-10, a cytokine produced primarily from monocytes
that serve to enhance B cell survival, proliferation and antibody production (28).
A limited number of studies have examined miRNA expression in inflammation related to
endodontic infection. Our previous study examined the differential expression of miRNAs in
inflamed and healthy pulps using microarray techniques (16). When comparing our
microarray data to that of our previous study, we see that there is significant differential
expression of 13 of the same miRNAs in both periapical and pulp tissues. These include:
miR-29a*, miR-30b*, miR-181a-2*, miR-181d, miR-455-5p, miR199-5p and miR-664. All
seven of the significantly down-regulated miRNAs identified in diseased periapical tissues
were also shown to be down-regulated in inflamed pulp tissue compared to healthy pulp
tissue. The six of which showed significant down-regulation in both tissues include:
miR-24-1*, miR-95, miR-181a*, miR-181b, miR-181c and miR-455-3p. The extent of this
cross-over suggests some common miRNA regulatory network in pulpal and periapical
disease pathogenesis. This could be due to similar inflammatory processes occurring in both
tissues. However, the tissue specificity of miRNAs is apparent in the difference between the
types of miRNAs identified in pulp and periapical tissues using microarray. Although some
overlap exists, it is possible that the other miRNAs identified in this study could be unique
to the periapical disease process.
In the present study we first identified differentially expressed miRNAs in diseased
periapical tissues as compared to healthy pulps using microarray analysis. We then collected
a separate cohort of healthy and diseased samples to validate these findings using qRT-PCR.
For this second experiment both pulp and PDL were used as control tissues. We included
PDL as a control as the normal periapex consist of PDL and bone tissue. Bone tissue was
not used as its removal is not recommended in apicoectomy procedures. It is also relatively
acellular. Despite using a separate cohort of samples for the qRT-PCR, the results confirmed
the down-regulation of the same miRNAs identified using microarray. Also, the same
miRNAs were consistently down-regulated in diseased periapical tissues when comparing to
both pulp and PDL control tissues. This correlation strengthens our findings and supports
the inclusion of the selected control tissues.
Chan et al. Page 6






















The limitations of this study include the absence of age matched controls. Participants in the
control groups consisted of individuals undergoing extraction of third molars or premolars
for orthodontic purposes. They were significantly younger than participants in the periapical
group who were patients undergoing apicocectomy surgery. We did not differentiate
between periapical cysts and granulomas nor did we differentiate between symptomatic and
asymptomatic teeth. Studies that implement in situ hybridization techniques could be used to
determine the cellular sources of the identified miRNAs and at the same time differentiate
between periapical cysts and granulomas. Future studies that include a larger number of
teeth with periapical lesions are needed to identify miRNAs that correlate with odontogenic
pain.
This study explores the role of miRNAs in endodontic disease and provides new insight into
the genetic regulation of endodontic periapical pathogenesis. This study offers potential
candidates for further investigation of miRNAs in endodontic disease. These findings could
facilitate the development of potential biomarkers and possible therapeutic targets for the
treatment of endodontic disease.
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Differential expression of miRNAs in healthy pulp (n = 5) and diseased periapical tissues (n
= 8) evaluated by microarray. Twenty-four miRNAs were significantly down-regulated in
diseased periapical tissues (P < .003, q < .08). Data was analyzed using an exact hypothesis
test and expressed as log values.
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Relative fold changes of seven miRNAs in diseased periapical and healthy pulp tissues
analyzed by qRT-PCR. Data was normalized to expression of endogenous control,
SNORD44. Relative expression computed using the 2(−ΔΔCt) method. **P ≤ .001
Chan et al. Page 10























Relative fold changes of seven miRNAs in diseased periapical and healthy periodontal
ligament tissues analyzed by qRT-PCR. Data was normalized to expression of endogenous
control, SNORD44. Relative expression computed using the 2(−ΔΔCt) method. * P ≤ 0.05, *
*P ≤ .001
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